Characterization of a novel mouse platelet transfusion model

Abstract

Background and ObjectivesPlatelet transfusions are increasing with medical advances. Based on FDA criteria, platelet units are assessed by in vitro measures; however, it is not known how platelet processing and storage duration affect function in vivo. Our study's aim was to develop a novel platelet transfusion model stored in mouse plasma that meets FDA criteria adapted to mice, and transfused fresh and stored platelets are detectable in clots in vivo.Study Design and MethodsPlatelet units stored in mouse plasma were prepared using a modified platelet‐rich plasma (PRP) collection protocol. Characteristics of fresh and stored units, including pH, cell count, in vitro measures of activity, including activation and aggregation, and post‐transfusion recovery (PTR), were determined. Lastly, a tail transection assay was conducted using mice transfused with fresh or stored units, and transfused platelets were identified by confocal imaging.ResultsPlatelet units had acceptable platelet and white cell counts and were negative for bacterial contamination. Fresh and 1‐day stored units had acceptable pH; the platelets were activatable by thrombin and adenosine diphosphate, agreeable with thrombin, had acceptable PTR, and were present in vivo in clots of recipients after tail transection. In contrast, 2‐day stored units had clinically unacceptable quality.ConclusionWe developed mouse platelets for transfusion analogous to human platelet units using a modified PRP collection protocol with maximum storage of 1 day for an ‘old’ unit. This provides a powerful tool to test how process modifications and storage conditions affect transfused platelet function in vivo.